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Rapid and specific detection of avian influenza (AI) virus is urgently needed with the concerns 
over the outbreaks of highly pathogenic H5N1 avian influenza in animal and human infection. 
Aptamers are artificial oligonucleic acid that can specifically bind to target molecules. They 
show comparable affinity for target virus and better thermal stability than monoclonal antibodies. 
Those advantages make aptamers promising candidates in diagnostic and detection applications. 
The goal of this research was to use DNA-aptamer as the specific recognition element in a 
portable surface plasmon resonance (SPR) biosensor for detection of AI H5N1 virus in poultry.  
A SPR biosensor was fabricated using the selected aptamers based on streptavidin-biotin method. 
Streptavidin was directly adsorbed onto the surface of a gold waveguide in the SPR biosensor. 
Then, biotinylated aptamers were immobilized on the sensor surface via streptavidin-biotin 
binding. The immobilized aptamers captured AI H5N1 virus in a sample solution, causing an 
increase in refraction index (RI). Performances of the aptamer-based SPR biosensor were studied 
in streptavidin modification, aptamer immobilization and virus detection. The optimal 
concentrations of streptavidin and aptamers were determined to improve the sensitivity of the 
biosensor. The response of the aptamer-virus interaction was shown to be virus titer-dependent, 
and a linear range for the titers of AI H5N1 was found between 0.128 and 1.28 HA unit. The 
aptamer-based SPR biosensor could detect the H5N1 virus at a titer greater than 0.128 HA unit 
within 1.5 h. No significant interference was observed from non-target subtypes such as AI 
H7N2, H9N2, H2N2, H1N1 and H5N2. The aptamer-based SPR biosensor was further evaluated 
for detection of AI virus in poultry swab samples. All of the AI viruses used in this study were 
killed ones to ensure biological safety. 
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Avian influenza (AI), also called “bird flu”, is an infectious disease of birds caused by type A 
strains of the influenza virus, causing huge economic losses in the world (WHO, 2012). The 
infection can cause a wide spectrum of symptoms in birds, ranging from mild illness, which may 
pass unnoticed, to a rapidly fetal disease that can cause severe epidemics (WHO, 2012). 
Generally, avian influenza viruses only infect birds, and do not normally infect humans (WHO, 
2012). However, recently, continuous outbreaks of avian influenza virus infection of humans 
have been reported in many countries since 2003: like the Republic of Korea, Viet Nam, Japan, 
Thailand, Cambodia, Lao People’s Democratic Republic, Indonesia, and China in Asia (WHO, 
2012). The first human case of avian influenza virus H5N1 infection was reported in Hong Kong 
in 1997 (WHO, 2012).  
Due to the different pathogenicity avian influenza can be divided into high-pathogenicity avian 
influenza (HPAI), low-pathogenicity avian influenza and non-pathogenic avian influenza 
(HDYK, 2005). Avian influenza virus has many serotypes among which H5 and H7 can cause 
human infection (HDYK, 2005).  
HPAI is a great threat not only for the poultry industry but also for humans, leading to high 
morbidity and mortality rate. There were a total 584 confirmed human cases and 345 deaths 
reported by WHO from 2003 until Feb. 8, 2012 (WHO, 2012). These events established that AIV 
H5N1 was considered a risk to public health. Also, high mortality rate and worldwide spread 
give humans much more concerns on AIV H5N1.  
The raised interest in the detection of AI H5N1 in humans as well as animals has been stimulated 
by increasing emergence of the infectious influenza diseases. A variety of technologies of 
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diagnosing AIV infection have been reported, including in vitro virus isolation by culture, 
serologic assays, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction 
(PCR)-based assays. To some extent, they are useful methods; however, many disadvantages 
make them less than ideal. For example, in vitro virus isolation by culture is time-consuming and 
needs about 10 days; the criteria for serologic detection of influenza virus, the hemagglutination 
inhibition (HI) assay, have been proved to have low sensitivity and cannot detect the kind of 
antibody that is against diverse avian influenza viruses (Rowe et al., 1999; Katz, 2003).; PCR-
based assays are more sensitive but plenty of mismatches between the primers and AIV 
sequences can happen and those assays cannot distinguish the live viruses from inactivated 
viruses (Fouchier et al., 2000; Suarez et al., 2003). Moreover, virus isolation, serological 
methods and PCR-based assays often require the lab workers to be highly trained, are time-
intensive procedures as well as require highly sterile experimental environment (Amano et al., 
2004; Chen et al., 2008). Dot-ELISA alone can only be used for qualitative rather than a 
quantitative detection. Therefore, in this research an aptamer-based SPR biosensor was studied 



















2.1  Overview of Avian Influenza 
2.1.1 Avian Influenza 
Influenza, or flu, is caused by RNA viruses of the Orthomyxoviridae family, infecting birds and 
mammals. Influenza can cause acute upper respiratory tract infection and is airborne through 
sneezes or coughs. Periodic pandemics around the world are often severe and occur rapidly, 
leading to considerate deaths of birds ranging from 250,000 to 500,000 annuly (WHO, 2009). 
Incidentally, viruses are transmitted from the wild waterfowl to other species and may then cause 
devastating outbreaks in domestic poultry or give rise to human influenza pandemics (Klenk et 
al., 2008).  
Influenza virus is a representative of Orthomyxoviridae, including human influenza virus and 
animal influenza virus. In virus taxonomy human influenza viruses are divided into three 
categories: influenza A virus, influenza B virus, and influenza C virus. Of the three viruses, type 
A viruses possess the strongest virulence and highest pathogenicity, causing the most severe 
disaster. Also, influenza A virus antigenically mutates easily, resulting in a number of worldwide 
pandemics, and it has a wide host range, including humans, pigs, birds and others, affecting very 
young, old and sick members of a population. Influenza B virus has low pathogenicity, and the 
host range is slightly narrower than that of Influenza A, covering humans and birds. While 
influenza C virus only causes asymptomatic or slight upper respiratory tract infection, hardly 
causing worldwide pandemic, and the host range is relatively narrow only involving in humans.  
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Influenza A viruses are actually avian viruses (Hay et al., 2001). Wild waterfowl provide natural 
hosts for many kinds of influenza A viruses. Influenza A viruses are subdivided into a number of 
different serotypes based on distinct combinations of hemagglutinin (HA) and neuraminidase 
(NA) that are the two major glycoproteins on the surface of the viral particles (Hay et al., 2001). 
Until today, 16 HA and 9 NA subtypes of influenza A viruses have been reported (Jong et al., 
2006). Theoretically, there may be 144 (16×9) subtypes of influenza A viruses. 
 
Figure 2. 1 Schematic diagram of influenza virus A. 
  
2.1.2 Avian Influenza Virus 
The HA protein is a homotrimeric integral membrane glycoprotein that plays a vital role in 
binding of the virus to target cells and penetration of the viral genome into the target cell during 
the process of virus infection. Influenza virus specificity for the host is mediated by the viral 
surface glycoprotein HA, which binds to receptors containing glycans with terminal sialic acids. 
Sialic acid is found on the surface of target host cells. The molecular-recognition process leads to 
the host cell-virus adhesion stage (Paulson et al., 1985). The sialic acid receptor of various 
influenza virus strains differs in affinity to sialic acids that are terminally linked either in α (2, 3) 










recognize α (2, 6)-linkage, while avian influenza virus has a preference for α (2, 3)-linkage 
(Rogers and Paulson, 1983).  
The HA protein is cylindrical and 13.5 nanometers in length. In order to fuse the endosomal and 
viral envelop, HA must be cleaved by proteinases from host cells to be active as a fusion protein 
(Flutrackers, 2007). HA is made up of three identical polypeptides. HA can be divided into two 
parts: HA1 and HA2 subunits after cleavage by cellular proteases. HA1, the globular head, can 
be found on the surface of the virus particle while HA2 is anchored in the viral envelope 
membrane. Although cleaved by cellular enzymes, HA1 and HA2 are still together on the viral 
surface. After cleavage, a very hydrophobic portion called fusion peptides is involved in the new 
N-terminal of HA2 caused by cleavage (Flutrackers, 2007). This so-called "fusion peptide" acts 
like a molecular grappling hook by inserting itself into the endosomal membrane and locking on. 
When infecting host cells, firstly, the HA1 subunit recognizes the monosaccharide sialic acid 
receptor on the surface of viral particles and binds to it. Then the viral particle will be engulfed 
to form an endosome. At that time, the cell tries to digest the content inside the endosome by 
decreasing the pH. However, when the pH value inside the endosome is reduced from 7.0 to 5.5, 
the globular head of the viral HA1 subunit unfolds backward to virion, releasing the very 
hydrophobic portion of HA2. Then, the hydrophobic portion—the fusion peptide—tightly inserts 
itself into the endosomal membrane like a sharp hook. HA2 generates a conformational change 
and draws the endosomal membrane close to the viral envelope resulting in the fusion of the viral 
and endosomal membranes. 
 8 
While HA is involved in binding to sialic acid groups from glycoproteins and entry into host 
cells, NA functions in release of progeny virus from infected cells by cleaving sialic acid groups 
that bind the mature viral particles and is responsible for virus replication. Otherwise, the release 
of the progeny virus particle is suppressed by the presence of HA-sialic acid binding. Therefore, 
 
 
Figure 2. 2 Influenza virus attachment and penetration. 
NA must cleave sialic acid groups from glycoprotein which is found on the host cell surface. The 
performance of NA’s function stimulates the release of the progeny virus into the infected host 
cell and promotes the viral replication in host cell. 
Additionally, an integral membrane protein also called M2 ion channel protein that is located in 
the surface of Influenza A virus is a channel protein which can select positive ions from the 
endosome (Sakaguchi, 1997; Jason and James, 2008). The M2 ion channel protein is made up of 
four identical molecules to form a homotetramer. Low pH before HA mediated fusion results in 
the activation of M2 protein (Sakaguchi, 1997; Jason and James, 2008). This channel protein 
plays an important role in the viral life cycle. It contributes to the entry of hydrogen ions from 
the endosome to viral particle and therefore lowers the pH inside viral particle, which leads to 
  HA2 






the HA’s conformational changes and degradation of matrix protein (M1) promoting the fusion 
of the viral and endosomal membranes. The mechanism of the anti-influenza A virus durgs 
amatidine and rimantidine is that the drug molecules bind to the transmembrane region of the 
virion and thus block the M2 ion channel, inhibiting the function of this protein and prevents 
uptake and uncoating of viral particle.  Thus, the drug should be taken early in infection. 
For the influenza viruses, two processes contribute to the changes of antigens on the surface of 
virus particles: antigenic drift and antigenic shift. Antigenic drift is the progressive accumulation 
of mutations within one subtype. During this process RNA encoding HA or NA proteins mutates 
leading to a new codon which will be translated into a new amino acid and further a new or 
mutated protein. Although the mutation is quite minor, it will prevent the vaccine against the 
previous virus from recognizing the antigen on the viral surface. Antigenic shift is described as 
the process in which two or more different strains of a virus, or strains of two or more different 
viruses, combine to form a new subtype having a mixture of the surface antigens of two or more 
original strains. Antigenic shift often occurs in any multiply-infected host, and causes immediate 
change in antigenic properties. For instance, birds and humans have α (2, 3) - and α (2, 6) - 
linkage to the galactose (Gal) residues respectively, while pigs have both of them. That means 
the viruses that are able to infect birds and humans can infect pigs simultaneously. When viruses 
replicate inside pig cell, pseudorecombination or reassortment can happen. A mixture of both 
genomes is produced. When antigenic drift and antigenic shift happen, people who have had the 
illness in the past will lost their immunity to the mutated subtype and vaccines against the 
original virus will also become less effective.   
 10 
The World Health Organization (WHO) published the formal nomenclature for the isolation of 
influenza viruses. The complete and correct nomenclature should include the type of influenza 
virus (A, B or C), the original host excluding human, the geographic origin of isolation, the strain 
number, the year of isolation (4-digit year if the influenza virus was isolated in 2000 or later; 2-
digit year if virus was isolated during the 1900s), and the subtype (16 HAs and 9 NAs) (CDC, 
2010). 
            
(a)                                                                             (b) 
Figure 2. 3 (a) Schematic diagram of influenza virus antigenic drift. RNA encoding HA or NA 
proteins mutates leading to a new codon which will be translated into a new amino acid and 
further a new or mutated protein. (b) Antigenic shift. 
 
For instance, a type A influenza virus that was isolated in 1997 from a chicken in Hong Kong 
with a stain number of 32 and an H5N1 subtype is named 
Influenza A/chicken/Hong Kong/32/97 (H5N1). 
            U     C    G    C    U    U    A     C    A    G    C    G 
            A     G    C    G     A    A    U    G    U    C    G    C 






If the virus was isolated from human, the name should be 
Influenza A/Hong Kong/32/97 (H5N1). 
 
Figure 2. 4 Nomenclature of avian influenza virus. 
 
2.1.3 Viral Inactivation 
Viral inactivation renders viruses inactive, or unable to infect. Many viruses contain lipid or 
protein coats that can be inactivated by chemical alteration. Viral inactivation is different from 
viral removal because, in the former process, the surface chemistry of the virus is altered and in 
many cases the viral particles remain in the final product. Rather than simply rendering the virus 
inactive, some viral inactivation processes actually denature the virus completely. Viral 
inactivation is used widely in the blood plasma industry. 
In order to achieve inactivation of the viruses in the sample, it is necessary to perform "special" 
purification processes that will chemically alter the virus in some way. Some of the more widely 
used processes are as follows: solvent/detergent inactivation; pasteurization (heating); acidic pH 
inactivation. 
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In some cases viral inactivation is not a viable removal alternative because even the denatured or 
otherwise inactivated viral particles can have deleterious effects on the process stream or the 
product itself. 
2.1.3.1 Solvent/Detergent (S/D) Inactivation 
This process is the most widely used viral inactivation method to date. It is predominantly used 
in the blood plasma industry (Mast et al., 1999). This process is only effective for viruses 
enveloped in a lipid coat, however (Horowitz et al., 1998). The detergents used in this method 
interrupt the interactions between the molecules in the virus's lipid coating (Mast et al., 1999). 
Most enveloped viruses cannot live without their lipid coating, so they die when exposed to these 
detergents. Other viruses may still live, but they are unable to reproduce, rendering them non-
infective. The solvent creates an environment in which the aggregation reaction between the lipid 
coat and the detergent happen more rapidly. The detergent typically used is Triton-X 100. 
This process has many of the advantages of the "traditional" removal techniques. This process 
does not denature proteins, because the detergents only affect lipids and lipid derivatives 
(Horowitz et al., 1998). There is a 100% viral death achieved by this process and the equipment 
is relatively simple and easy to use. Equipment designed to purify post-virus inactivated material 
would be necessary to guard against contamination of subsequent process streams. 
S/D treatment utilizes readily available and relatively inexpensive reagents, but these reagents 
must be removed from the product prior to distribution which would require extra process steps. 
Because this process removes/inactivates the lipid coating of a virus, viruses without any sort of 
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lipid envelope will be unaffected. There is also no inactivation effect by the buffers used in this 
process. 
2.1.3.2 Pasteurization  
Inactivation of viruses by means of pasteurization can be very effective if the proteins that you 
are trying to protect are more thermally resistant than the viral impurities with which they are in 
solution. Some of the more prominent advantages of these types of processes are that they 
require simple equipment and they are effective for both enveloped and non-enveloped viruses 
(Schlegel et al., 2001). Because pasteurization involves increasing the temperature of solution to 
a value that will sufficiently denature the virus, it does not matter whether the virus has an 
envelope or not because the envelope alone cannot protect the virus from such high temperatures. 
However, there are some proteins which have been found to act as thermal stabilizers for viruses. 
Of course, if the target protein is not heat-resistant, using this technique could denature that 
target protein as well as the viral impurity. Typical incubation lasts for 10 hours and is performed 
at 60°C (Schlegel et al., 2001). 
2.1.3.3 Acidic pH Inactivation 
Some viruses, when exposed to a low pH, will denature spontaneously. Similar to pasteurization, 
this technique for viral inactivation is useful if the target protein is more resistant to low pHs 
than the viral impurity. This technique is effective against enveloped viruses (Nicola et al., 2003), 
and the equipment typically used is simple and easy to operate. This type of inactivation method 
is not as effective for non-enveloped viruses however, and also requires elevated temperatures. 
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So in order to use this method, the target protein must be resistant to low pHs and high 
temperatures (Scholtissek, 1985) which is unfortunately not the case for many biological proteins. 
Incubation for this process typically occurs at a pH of 4 and lasts anywhere between 6 hours and 
21 days. 
2.1.3.4 Ultraviolet (UV) Inactivation 
UV rays can damage the DNA of living organisms by creating nucleic acid dimmers (Kumar et 
al., 2004). However, the damages are usually not important due to low penetration of UVs 
through living tissues. UV rays can be used, however, to inactivate viruses since virus particules 
are small and the UV rays can reach the genetic material, inducing the dimerisation of nucleic 
acids. Once the DNA dimerised, the virus particules cannot replicate their genetic material which 
prevent them from spreading (Goodrich et al., 2010). 
UV light in combination with riboflavin has been shown to be effective in reducing pathogens in 
blood transfusion products (Ruane et al., 2004). Riboflavin and UV light damages the nucleic 
acids in viruses, bacteria, parasites, and donor white blood cells rendering them unable to 
replicate and cause disease (Kumar et al., 2004; Goodrich et al., 2010). 
2.2 Current Diagnostic Methods  
2.2.1 Embryonated Egg Culture 
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Virus isolation in the amniotic cavity of embryonated hens’ eggs is a classical method for the 
direct recovery of influenza virus from a clinical specimen (Oxford et al., 1991). Embryonated 
eggs are among the most useful and available forms of living animal tissue for the isolation and 
identification of animal viruses, for titration viruses, and for quantity cultivation in the 
production of viral vaccines (Joseph, 2008). The embryo proper, chorioallantoic membrane, yolk 
sac, allantoic sac, or amniotic sac may be inoculated in hen eggs of various ages, so that a wide 
choice of types of tissue is available to fit the characteristics of the virus under study or for 
special studies.  The chorioallantoic membrane is frequently used; in some infections, such as 
smallpox, vaccinia, and herpes simplex, characteristic lesions are produced which in some cases 
may resemble those in the natural host (Joseph, 2008). For example, smallpox virus when 
cultured on the chorioallantoic membrane produces pocks and typical inclusions within the 
infected cells. When the embryo is inoculated, characteristic skin eruptions appear. Influenza 
virus, however, when inoculated into the amniotic cavity, does not give rise to pathology like 
that of the natural infection (Joseph, 2008). 
The growth of influenza virus in the allantoic cavity of embryonated eggs is probably the best-
known use of eggs for animal virus culture. After inoculation into the allantoic cavity, the 
number of virus particles decreases exponentially, with almost 50% adsorbed to cells within 1 h. 
After adsorption the virus particles disappear (presumably by penetration of the cells), and an 
“eclipse period” of about 4 h follows. Evidence of viral multiplication first appears in the middle 
of the eclipse period, when soluble complement-fixing antigen (noninfective and 
nonhemagglutinating) is detectable. Hemagglutinating antigens can be found 3–4 h following 
inoculation, but in no greater amount than in the original inoculum; increases in 
hemagglutinating activity are seen only after 4 h or more. Infective virus is detectable 5–6 h after 
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the allantoic cavity is inoculated; it is released almost at once into the allantoic fluid. Infective 
virus particles thus released then infect other cells of the allantoic sac, and virus continues to 
accumulate in the allantoic fluid for about 48 h, after which the system is exhausted (Joseph, 
2008). 
Embryonated egg culture is a classical method for virus, but a couple of disadvantages cannot be 
ingored. Growth of human influenza virus in eggs can lead to the selection of variants that differ 
antigenically from the original seed virus (Hickling and D’Hondt, 2006). Individual virus isolates 
may exhibit different growth characteristics in eggs, thereby affecting the yield of the viruses 
(Hickling and D’Hondt, 2006). 
2.2.2 Hemagglutination Inhibition (HI) Assay  
In order to understand the HI assay well, the hemagglutination assay should be introduced first. 
Hemagglutinin, or HA is an envelope protein on the influenza virion, which is able to bind to the 
sialic acid receptors found on the surface of host cell. The virus can also bind to the N-
acetylneuraminic acid on the surface of erythrocytes (red blood cells), which results in 
agglutination of red blood cells (Amano and Cheng, 2005). This process is named 
hemagglutination and forms the foundation of a rapid assay to determine the concentration of 
influenza virus in a sample. For HI assays, a virus dilution (e.g. two-fold serial dilution) will be 
mixed with a specific amount of red blood cells, and then added to the wells of a plastic 96-well 
plate for 30-min incubation. The red blood cells will precipitate at the bottom of the well if they 
do not bind to the influenza virus, forming a red circular dot, while the red blood cells that are 
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bound by influenza virus will agglutinate to form a lattice like a film covering the bottom of the 
well (Virology blog).  
Take the test below as an example: eight different influenza viruses (A to H) are two-fold serially 
diluted, applied to a chicken red blood cell solution, and placed into the wells of a 96-well plate. 
The results can be detected after 30-min incubation. Sample A doesn’t cause red blood cell 
precipitation up to the 1: 256 dilution, thus the HA titer of this virus stock is 256. No virus can be 
detected in sample B and C. Sample D has an HA titer of 512.  
HA assay is the foundation of hemagglutination inhibition assay. Antibodies against the viral 
protein responsible for hemagglutination can inhibit binding of virus to red blood cells and   
hemagglutination cannot occur. The advantage of HA-HI assay is that currently it is applied by 
WHO to detect the influenza viruses globally, and can detect all influenza virus isolates and viral 
infection and antibody present in the serum (Amano and Cheng, 2005). HI assay is relatively 
easy and inexpensive to perform. However, its disadvantages cannot be neglected. HI has been 
shown to be less sensitive for the detection of antibodies induced by avian influenza viruses 
(Rowe et al., 1999). Accurate reading skills are also required for the complicated assay (Amano 
and Cheng, 2005).  
If the antibodies against the viral protein are included in the serum, the hemagglutination will not 
happen until the serum is diluted sufficiently. On the contrary, the hemagglutination will be 
detected if the serum doesn’t contain antibodies preventing hemagglutination (Amano and Cheng, 
2005).  
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2.2.3 Enzyme-linked Immunosorbent Assay (ELISA) 
Enzyme-linked immunosorbent assays (ELISA) were introduced in the 1970s. ELISA also 
known as enzyme immunoassay (EIA) is a biochemical technique used mainly in immunology to 
detect the presence of an antibody or an antigen in a given sample (Crowther, 2001). A kind of 
antibody specifically against a particular antigen is required in an ELISA. For traditional ELISA, 
a 96-well polystyrene microtiter plate is used as a solid vector for immobilization of a given 
sample with an unknown amount of antigen. After that, a detectable antibody as primary 
antibody is added, causing specific antigen-antibody reaction. A secondary antibody that 
biologically conjugates with an enzyme is added, covalently binding to the primary antibody. 
After every addition of sample, the free antibodies should be removed by washing with a mild 
washing solution. In the final step, an enzymatic substrate is applied to the plate, and a visible 
signal can be showed approximately indicating the quantity of antigen in the given sample 
(Crowther, 2001). Commonly in ELISA there are two antigen-antibody reactions which occur 
just after the addition of primary antibody and secondary antibody, respectively. Antigen-
antibody reaction occurs under certain temperature. The incubation temperature is 37℃ for 
ELISA.  
Due to the disadvantages of traditional ELISA such as too much false positive, more reagent 
used, and results that cannot be saved, Dot-ELISA technique was developed. Dot-ELISA utilizes 
nitrocellulose (NC) membrane as solid vector which has stronger absorption to proteins than 
polystyrene. A little amount of unknown antigen is added on the NC membrane, followed by the 
addition of primary antibody and secondary antibody. Finally, signal substrate that can generate 
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visibly insoluble precipitation with the secondary antibody is applied onto the NC membrane. 
The room temperature is suitable for Dot-ELISA. 
In short, Dot-ELISA has the same principle as traditional ELISA (Belo et al., 2010). However, 
Dot-ELISA has more advantages than traditional ELISA, such as better sensitivity, simplicity of 
performance, no need for complex laboratory equipment, and fast speed (Belo et al., 2010).  
2.2.4 Polymerase Chain Reaction (PCR) 
2.2.4.1 Traditional Polymerase Chain Reaction 
The polymerase chain reaction (PCR) was developed in 1980s by Mullis (Bartlett et al., 2003). 
PCR is a scientific technique in molecular biology to amplify a single or a few copies of a piece 
of DNA across several orders of magnitude, generating thousands to millions of copies of a 
particular DNA sequence. PCR has played a very essential role in medical and biological 
research for a variety of applications since it was developed. PCR technique is applied in DNA 
cloning for sequencing, functional analysis of genes, diagnosis of hereditary diseases, the 
identification of genetic fingerprints and the detection, diagnosis of infectious diseases, etc.   
PCR is used to in vitro duplicate DNA strand that is complementary to the template DNA with 
the help of enzymatic DAN polymerase and specific primer as the start point of extension. PCR 
requires thermal cycling, including circular procedure of heating and cooling of the reaction in 
denaturation, annealling, and extension. Several components and reagents are utilized in PCR 
process covering template DNA with the target, primer, four deoxynucleoside triphosphates 
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(dNTPs), and DNA polymerase. The primer is actually a piece of DNA fragment with known 
sequence that can bind to the complementary region in DNA template, and performs as a binding 
site of DNA polymerase to direct DNA replication.   
PCR has higher sensitivity than ELISA and relatively shorter performance time than viral culture 
(24 to 36h versus 2 to10 days) (Robert et al., 1996; Joanna et al., 2002). The disadvantages of 
PCR involve in cost, false positive, intricate procedure, and possibility of contamination (Joanna 
et al., 2002). Additionally, to evaluate the amplicated products during PCR, laborious post-PCR 
handling steps are required, that is to say, much more time is needed (Lan et al., 2002). Moreover, 
EB may cause cancer due to its inhibition of RNA, DNA and protein synthesis (NTP, 2005). EB 
should be avoided to touch directly.  
2.2.4.2 Reverse Transcription PCR 
With increasing development of PCR technique, many variations on the basic PCR technique 
have gradually been introduced into the research fields. Reverse Transcription PCR (RT-PCR) is 
a good example. Most recently, PCR, especially RT-PCR has been greatly developed as an 
extremly effective technique for DNA amplification, viral detection, typing and subtyping 
(Zhang et al., 1991). During RT-PCR, a single-strand RNA is reversely transcribed into a 
complementary DNA (cDNA) by the reverse transcriptase. Then a new DNA strand 
complementary to cDNA is synthesized directed by the deoxynucleotide primer and DNA 
polymerase. Exponential growth is developed with every cycle. The previous single-strand RNA 
is degraded by RNase H, leaving cDNA. 
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Figure 2. 5 Schematic diagram of the PCR cycle. A single copy of a piece of DNA was 
amplified to several orders of magnitude through denaturation, annealing, and extension of PCR.  
2.2.4.3 Real Time RT-PCR 
Sometimes RT-PCR refers to the real-time PCR. To distinguish it from reverse transcription 
PCR, real-time PCR is commonly called quantitative PCR, or real-time quantitative PCR, or 
abbreviated to RTQ-PCR, Q-PCR, or QRT-PCR. Real-time PCR is a process by which the 
increase of DNA can be detected with the ongoing amplification cycles with the help of a 
fluorescent reporter molecule. The amount of specific product depends on the intensity of the 
fluorescence, predicting the initial amount of target gene without product isolation.  
There are two major kinds of fluorescent reporters used in real time RT-PCR, which are general 
non-specific DNA binding dyes such as SYBR green and TaqMan Probes. As for the former, 
excessive SYBR green is added to the PCR reaction system, and fluorescent signal is emitted if 
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SYBR green specifically binds to the double-strand DNA, while SYBR green cannot generate 
fluorescent signal if it doesn’t bind to DNA strand to ensure simultaneous increase of fluorescent 
signal and PCR product. To the latter, a specific TaqMan probe is applied to the PCR system at 
the same time of addition of primers. The TaqMan probe is an oligonucleotide labeled at both 
ends with fluorophore and quencher. Fluorescent signal generated by fluorophore is absorbed by 
quencher if the probe is complete. During PCR amplification, TaqMan probe is enzymatically 
degraded by Taq polymerase, separating fluorophore and quencher. Therefore, fluorescent signal 
can be detected. Every formation of new DNA strands brings a fluorescent signal, fulfilling the 
simultaneous increase of fluorescent signal and PCR product.  
The fluorescent signal is continuously determined in real time during the amplification processes, 
and can form a curve with time going on. During the early phase of PCR, the thermal cycler 
cannot distinguish the fluorescence signal from the background noise, and later, the curve of 
dynamic process shows an exponential growth of fluorescence signal. However, actually the 
reaction doesn’t always show a standard exponential curve but a “S” curve due to the 
inactivation of DNA polymerase, depletion of dNTP and primer, and the resistance of by-product 
as the cycles increased. The linear phase and plateau of fluorescence signal are followed by the 
exponential growth phase. Consequently, amplicons can be determined at one point within 
exponential growth phase due to excellent reproducibility in this phase so that the initial amount 
of template will be obtained.  
Quantitative PCR technique makes it possible to detect gene amplicons during PCR taking place 
in real time. To meet the need of experimental purposes, very often real time PCR and reverse 
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transcription PCR are integrated to detect specific target gene using trace amount of template 
RNA in real time. The combination of both PCR is called quantitative RT-PCR (qRT-PCR).  
PCR techniques have considerably contributed to the viral detection especially the influenza 
virus detection. However, PCR cannot separate the live virus from the inactivated virus, causing 
a false positive result (Suarez et al., 2003). Moreover, conventional PCR is a time-consuming 
technique with improtant limitations when compared to real-time PCR technique due to the 
requirement of post-PCR (Lan et al., 2002).   
2.3 Aptamers  
Aptamers are artificial oligonucleic acid or peptide molecules that can bind to a specific 
molecule with high affinity and selectivity, such as viruses. Aptamers were developed in 1990 
within two independent labs: the Gold lab (Tuerk and Gold, 1990) and the Szostak lab (Ellington 
and Szostak, 1990) in the USA. In Gold lab, high-affinity nucleic acid ligands for a protein were 
isolated by a procedure that depends on alternate cycles of ligand selection from pools of variant 
sequences and amplification of the bound species, and multiple rounds exponentially enrich the 
population for the highest affinity species that can be clonally isolated and characterized (Tuerk 
and Gold, 1990). Subpopulations of RNA molecules that bind specifically to a variety of organic 
dyes isolated from a population of random sequence RNA molecules in Szostak lab (Ellington 
and Szostak, 1990). Aptamers are usually created by selecting them from a large random 
sequence pool. They can be applied for basic research as well as clinical purposes. More 
specifically, aptamers can be classified as DNA or RNA aptamers which consist of (usually short) 
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strands of oligonucleotide, and peptide aptamers including a short variable peptide domain. 
Nucleic acid aptamers are usually investigated.  
2.3.1 Selection of Aptamers 
Nucleic acid aptamers have been developed through an in vitro selecting technique called 
systematic evolution of ligands by exponential enrichment, abbreviated as SELEX, and the 
resulted oligonucleotides are referred to as aptamers, derived from the Latin aptus meaning ‘to 
fit’ (Sumedha, 1999). The SELEX process begins with a random sequence library consisting of 
randomly generated sequences of fixed length flanked by constant 5’ and 3’ ends that serve as 
primers and the library is obtained from combinatorial chemical synthesis of oligonucleotides 
(Ciara, 2001). Consequently the very combinatorial libraries of oligonucleotides are screened by 
a repeated process of in vitro selection and amplification (Ciara, 2001). Each member in a library 
is a linear oligomer of a unique sequence and the molecular diversity is dependent on the number 
of randomized nucleotide positions (Ciara, 2001).  
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Figure 2. 6 Schematic indicating steps involved in aptamer selection using the SELEX process 
starting with target ligands. The SELEX process begins with a random sequence library. The 
very combinatorial libraries of oligonucleotides are screened by a repeated process of in vitro 
selection and PCR amplification.  
In the screening process, a random sequence oligonucleotide library is incubated with a target of 
interest in a buffer of choice at a given temperature. During the cycles of selection, a very small 
fraction of individual sequences bind with the target, and these sequences are separated from the 
rest of the library by some physical separation techniques such as affinity chromatography or 
filter binding (Burke and Gold, 1997). The population of sequences bound to the target is 
isolated and amplified to obtain an enriched library to be used for the following 
selection/amplication cycle. The efficiency of enrichment of high-affinity binders is governed by 
the stringency of selection of each round, and the number of cycles required for aptamer 
identification is usually dependent on the degree of stringency imposed at each round as well as 
the nature of the target (Sumedha, 1999). The progress of the enrichment of high-affinity binders 
can be determined by carrying out binding analysis of enriching populations against the target. 
When affinity saturation is reached after several rounds of selection/amplification, the enriched 
pool is cloned and sequenced to obtain the sequence information (Sumedha, 1999). Individual 
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sequences are further characterized on the basis of their ability to bind to the target. In the end, 
the counter selection is employed to effectively discard ligands that have the ability to bind the 
closely related structural analogs of the target, resulting in aptamer sequences with high 
specificity (Jenison et al., 1994). Aptamers can then be truncated as desired, eliminating the fixed 
primer sequences and the nucleotide stretches that are not important for direct interaction with 
the target or for folding into the structure that facilitates target binding (Sumedha, 1999). When 
the desired sequence has been identified the aptamer can be produced in sizeable quantities by 
chemical synthesis.  
2.3.2 Comparison between Aptamers and Antibodies 
Nucleic acid aptamers are often considered as artificial antibodies. However, when compared to 
antibodies, aptamers have considerable advantages that make them more conspicuous and more 
potential in analytical and diagnostic application than antibodies. The main advantage of 
aptamers is that they can be selected in vitro, while the antibodies have to be obtained in vivo 
through induction of an immune response in a biological system. Antibodies function only under 
physiological conditions, which limit the application and function of antibodies. The immune 
system couldn’t respond to the targets or toxic compounds which have similar structure to the 
endogenous protein but are harmful to the biological system. Otherwise, aptamers can be specific 
against any target molecules and applied for any condition not only in vivo but also in vitro. 
Moreover, aptamers are more stable at high temperature, and can stand boiling for several 
minutes but doesn’t denature, resulting in a longer shelf life than antibodies.  
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The SELEX selection process usually takes about 8 weeks for the development of an aptamer 
and while antibody selection will have to take up to 6 months. Therefore, a plenty of time will be 
saved when compared to the in vivo selection process for antibodies.  
Aptamers can be manipulated to bind different region of the target in different conditions. 
Therefore, high-quality aptamers can be obtained after they are synthesized chemically and then 
purified to a very high degree by eliminating the batch-to-batch variation which can be found for 
antibodies, leading to good stability, strong affinity and high specificity of aptamers. The 
comparison of properties of antibodies and aptamers are listed in the table below.  
Table 2. 1 Comparison of the properties of antibodies and aptamers. 
 
                      Antibodies                                                                                 Aptamers 
            Biological system required                                                      In vitro selection process 
                 Animals required                                                                     No need of animals 
      Target for immunogenic proteins                                                     Target for any proteins 
               Limited modifications                                            Chemical modifications result in high specificity. 
  Unstable, poor high-temperature resistance                                  Stable, excellent heat resistance 
                    Short shelf life                                                                      Unlimited shelf life 
           Time consuming and expensive                                                    Short selection time 
 May undergo denaturation after high temperature.           Denatured aptamers can be regenerated within minutes. 
 Antibodies often suffer from batch to batch variation.      Aptamers are produced by chemical synthesis resulting  
                                                                                                        in little or no batch to batch variation.                                                                       
 
2.3.3 Aptamers Against AI 
The raised interest in the detection of AI in humans as well as animals has been stimulated by 
increasing emergence of the infectious influenza diseases and also the development of various 
aptamers. A variety of aptamer-based technologies have been used to detect AI. Choi et al. (2011) 
selected DNA aptamers against the receptor binding region of hemagglutinin and those aptamers 
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can prevent avian influenza viral infection. In this study, they cloned the cDAN fragment which 
encoded the whole globular region of hemagglutinin of the H9N2. As we know, the entrance of 
influenza virus into host cells is facilitated by the attachment of the globular region of viral 
hemagglutinin to the sialic acid receptors on host cell surfaces (Choi et al., 2011). To identify 
specific DNA aptamers with high affinity to H9 peptide, they conducted the SELEX method. 19 
aptamers were isolated, and a random mixture of these aptamers showed an increased level of 
binding affinity to the H9 peptide (Choi et al., 2011). The sequence alignment analysis of these 
aptameres revealed that 6 aptamers have highly conserved consensus sequences. Among these, 
aptamr C7 showed the highest similarity to the consensus sequences. This aptamer showed 
strong binding capability to the viral particles which suggest that this apatmer can recognize the 
hemaglutinin protein of AIV and inhibit the binding of the virus to target receptors (Choi et al., 
2011). 
Another paper by Park et al. (2011) reported that RNA aptamer candidates targeting the 
biologically active HA protein were selected after 15 rounds of interative SELEX. The selected 
RNA aptamer HAS 15-5, which specifically binds to HA1 that is the receptor binding domain of 
HA protein, exhibited significant antiviral efficacy according to the results of a hemagglutination 
inhibition assay using egg allantoic fluids harboring the virus (Park et al., 2011). Thus, the RNA 
aptamer HAS15-5, which acts by blocking and inhibiting the receptor-binding domain of viral 
HA, can be developed as a novel antivial agent against type H5 AIV (Park et al., 2011). 
Gopinath et al. (2005) isolated aptamers specific for hemagglutinin protin of human influenza 
virus B/Johannesburg/05/1999. The selected aptamers, Class A-20, bind specifically to 
hemagglutinin of B/Johannesburg/05/1999 and able to discriminate it from hemagglutinin of 
human influenza A virus (Gopinath et al., 2005). 
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In Dr. Yanbin Li’s lab in University of Arkansas, another type of DNA aptamer against H5N1 
was selected using an in vitro SELEX. In this study, the mixture of DNA pool and H5N1 viruses 
passed through a nitrocellulose filter (Zhao, 2011). The aptamers with the affinity and specificity 
to H5N1 kept on the filter surface, and the rest of the pool were washed away. Then, the DNA 
aptamer candidates were amplified by PCR. Single-stranded DNA aptamers were obtained 
through λ digest of a dsDNA stock. Lambda exonuclease that is a 5’ to 3’ exodeoxyribonuclease 
is able to digest the 5’-phosphorylated strand of dsDNA (Zhao, 2011). The ssDNA was applied 
for the next cycle, and ssDNA aptamers with higher affinity and specificity were obtained 
through interative separation-amplification cycles (Zhao, 2011). 
2.4 Biosensors for Detection of Avian Influenza 
Worldwide, there are many strains of avian influenza virus that cause varying degrees of clinical 
symptom and illness. In the United States, outbreaks of the disease – primarily spread by 
migratory aquatic birds – have plagued the poultry industry for decades with millions of dollars 
in losses. The only way to stop the spread of the disease is to destroy all poultry that may have 
been exposed to the virus. Quick identification of avian influenza infection in poultry is critical 
to controlling outbreaks, but current detection methods can require several days to produce 
results. Current interest has focused on developing new sensors for quick and reliable testing for 
influenza with minimum sample handling and laboratory skill requirement. In recent years, 
various biosensors have been studied as an alternative to conventional methods for detection of 
influenza viruses. 
2.4.1 Introduction of Biosensors 
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A biosensor is an analytical device which converts a biological response into an electrical signal. 
Biosensors can provide reliable, real-time, on-field, user-friendly, and inexpensive analysis with 
improved or equivalent sensitivity, specificity and reproducibility of culture-based tests (Alocilja 
et al., 2003). A successful biosensor must possess at least some of the following beneficial 
features:  
The biocatalyst must be highly specific for the purpose of the analyses, be stable under normal 
storage conditions and, except in the case of colorimetric enzyme strips and dipsticks, show good 
stability over a large number of assays (i.e. much greater than 100).  
The reaction should be as independent of such physical parameters as stirring, pH and 
temperature as is manageable. This would allow the analysis of samples with minimal pre-
treatment. If the reaction involves cofactors or coenzymes these should, preferably, also be co-
immobilised with the enzyme.  
The response should be accurate, precise, reproducible and linear over the useful analytical range, 
without dilution or concentration. It should also be free from electrical noise.  
If the biosensor is to be used for invasive monitoring in clinical situations, the probe must be tiny 
and biocompatible, having no toxic or antigenic effects. If it is to be used in fermenters it should 
be sterilisable. This is preferably performed by autoclaving but no biosensor enzymes can 
presently withstand such drastic wet-heat treatment. In either case, the biosensor should not be 
prone to fouling or proteolysis.  
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The complete biosensor should be cheap, small, portable and capable of being used by semi-
skilled operators.  
There should be a market for the biosensor. There is clearly little purpose developing a biosensor 
if other factors (e.g. government subsidies, the continued employment of skilled analysts, or poor 
customer perception) encourage the use of traditional methods and discourage the 
decentralisation of laboratory testing.  
A biosensor is an analytical device for the detection of an analyte that combines a biological 
component with a physicochemical detector component. It consists of 3 parts: The sensitive 
biological element (biological material (e.g. tissue, microorganisms, organelles, cell receptors, 
enzymes, antibodies, nucleic acids, etc.): a biologically derived material or biomimic component 
that interacts (binds or recognises) the analyte under study. The biologically sensitive elements 
can also be created by biological engineering. 
The transducer or the detector element (works in a physicochemical way; optical, piezoelectric, 
electrochemical, etc.) that transforms the signal resulting from the interaction of the analyte with 
the biological element into another signal (i.e., transducers) that can be more easily measured 
and quantified; 
Biosensor reader device with the associated electronics or signal processors: this part is primarily 
responsible for the display of the results in a user-friendly way. This sometimes accounts for the 
most expensive part of the sensor device. However it is possible to generate a user friendly 
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display that includes transducer and sensitive element. The readers are usually custom-designed 
and manufactured to suit the different working principles of biosensors.  
In general, the application of the transducer in the analytical system separates the biosensors 
from conventional assays. Depending on the transduction mechanism, the biosensor includes 
electrochemical, optical and piezoelectric biosensors.  
2.4.2 Biosensors for Detection of Avian Influenza 
Influenza is an acute respiratory disease caused by the influenza virus. The disease occurs 
annually, causing fatality in the elderly and children and billions of dollars loss in business and 
productivity. Although traditional viral detection methods are effective, these methods generally 
involve labor-intensive laboratory procedures and often require trained personnel to carry them 
out. The development of biosensor technologies will enable rapid and specific disease diagnosis 
on-site so that a clinician can quickly determine whether treatment is needed. Biosensors will 
have an impact on people’s daily lives in the not too distant future, since they can fill very real 
need in health care, environmental monitoring and control, agriculture and chemical industries.  
There is much interest in developing new influenza sensors for quick and reliable testing for 
influenza with minimum sample handling and laboratory skill requirement. One of the strategies 
is to develop single step direct sensing methods that eliminate separation, incubation or use of 
any signal-reporting agents. In recent years, non-labeling techniques such as surface plasmon 
resonance (SPR) and quartz-crystal microbalance (QCM) have shown high promise in sensor 
research and gained momentum in detection of viral samples. Detection limits of QCM and SPR 
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are both around the sub-nanogram region. Because the molecular weight of influenza A/B virus 
is about 2.5×106, the detectable number of virions is considered to be around 106 (Yoshihisa and 
Quan, 2004).  
For example, the impedance biosensor is a class of electrical biosensors that show promise for 
point-of-care and other applications due to low cost, ease of minizturization, and label-free 
operation (Daniels and Pourmand, 2007). Impedance biosensors include two electrodes with 
applied altemating voltage, amplitudes from a few to 100 mV are used (Pohanka and Skladal, 
2008). There have been some promising approaches of impedance biosensors. Hybridization of 
DNA fragments previously amplified by PCR has been monitored by an impedance assay 
(Pohanka and Skladal, 2008). A portable impedance biosensor for detection of avian influenza 
virus was also evaluated by Wang et al. (2011). In the impedance biosensor system, the magnetic 
nanobeads were coated with AIV subtype-specific antibody for immobilization of a target virus, 
and a microfluidic chip with an interdigitated array microelectrode was used for transfer and 
detection of target virus (Wang et al., 2011). The impedance of the bio-nanobeads and AI virus 
complexes in a buffer solution can be measured based on a combination of magnetic nanobeads 
and a microfluidic chip (Wang et al., 2011).   
Additionally, surface plasmon resonance is a direct optical-sensing technique that measures the 
refractive index change due to biospecific interactions occurring in the vicinity of a thin metal 
film surface. Its label-free detection scheme together with very high sensitivity offers enormous 
opportunity and flexibility to biosensing assay development. Judging from the increasing number 
of publications, it is clear that surface plasmon resonance has become one of the most attractive 
techniques for detection of various biochemical analytes. Surface plasmon resonance has been 
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used for detection of influenza virus and the study of interactions that involve viral proteins and 
receptors. The first use of SPR in influenza virus detection was reported by Schofield and 
Dimmock (Schofield and Dimmock, 1996). The sensor chip was coated with carboxylated 
dextran polymer matrix, on which monoclonal antibody HC10 for capture of influenza virus was 
coupled. Influenza virus was injected into the flow system, and the binding affinity with the 
surface antibody was monitored. This study demonstrated that the feasibility of affinity 
measurements and detection for large virus particles by SPR. 
2.4.3 Aptamer-based Biosensors (Aptasensor) 
The nucleic acid aptamers are the one type of synthetic ligands that have the potential for various 
biosensing applications. Aptamers are single strand nucleic acid ligands, and the ability of 
aptamers to bind their target molecule with high specificity and other advantages make them a 
good tool for therapeutic, diagnostic and analytical application, such as mediation for tumor cell 
lysis (Jing et al., 2010; Boltz et al., 2011), cancer detection or therapy (Medley et al., 2011; 
Rialon and White, 2011; Zhu et al., 2010), nanoparticle-based detection using aptamer (Song et 
al., 2011; Wang et al., 2011; Medley et al., 2011; Chen et al., 2011), and aptamer-based 
biosensors (Ma et al., 2010; Sassolas et al., 2011; Liu et al., 2010; Qureshi et al., 2010). They are 
especially well suited as biosensors.  
Aptamer-based electrochemical biosensor was applied to detect the interferon gamma (IFN-γ) 
produced by a number of immune cell types including T-helper (CD4) cells and cytotoxic T-cells 
by Ying et al. (2010). In this research, IFN-γ binds to the DNA aptamer, consequently forming 
the aptamer-IFN-γ complex. Then, methylene blue (MB) redox tag was conjugated with the 
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aptamer- IFN-γ complex. By self-assembly technique, the aptamer-IFN-γ-MB compounds are 
immobilized on the gold surface of the electrode. The DNA aptamers unfold due to the IFN-γ 
binding, and so the MB redox molecules are forced to move away from the electrode, which 
lowers the electron-transfer efficiency and subsequently the redox current is changed (Ying et al., 
2010). An electrochemically voltammetric biosensor is used to measure the change in redox 
current highly proportional to IFN-γ concentration. The minimum limited concentration of IFN-γ 
for this aptasensor was 0.06 nM. Moreover, regeneration of the same aptasensor is performed by 
breaking down the bound aptamer-IFN-γ complex in urea buffer, and the sensor can be reused 
multiple times (Ying et al., 2010).   
The aptamer has already been applied in capacitive biosensor for the detection of C-reactive 
protein by Anjum et al. (2010). C-reactive protein (CRP) is a biomarker for cardiovascular 
disease risk (CVR) and can be biorecognized by the RNA-aptamer in this research. Anjum et al. 
used a RNA-aptamer-based biosensor for measuring transducing aptamer-CRP recognition 
events based on charge distribution under the applied frequency by non-Faradaic impedance 
spectroscopy (NFIS) (Anjum et al., 2010). RNA aptamer is immobilized in the thin layers on the 
gold interdigitated (GID) electrode. Consequently, the charge distribution changes with the 
formation of RNA-CRP complex when CRP binds, following the signal generation in terms of 
capacitance. Previously, antibody-based capacitive biosensor for CRP detection has been 
reported, but antibodies show inactivation over a period of time (Quershi et al., 2009; Anjum et 
al., 2010). Therefore, the utility of aptamer in this study overcomes the drawback of antibodies.  
Also, the aptamer was applied as a molecular recognition element in a fluorescent biosensor for 
measurement of potassium ion using a pyrene-labeled molecular beacon (Chao et al., 2010). The 
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pyrene is used to label the 5’ end and 3’ end of complementary oligonucleotide with the aptamer. 
When K+ is added the complementary oligonucleotides will move away from the aptamers. The 
two pyrene moieties are drawn very close to each other due to the self-hairpin structure of the 
complementary oligonucleotide, resulting in the release of pyrene fluorescence (Chao et al., 
2010). The fluorescence intensity of pyrene is proportional to the concentration of K+. However, 
only monomer (the complementary oligomer conjugated with aptamers) is produced in the 
absence of K+.  
Several aptamer-based biosensors for detection of various viruses have been reported including 
those specific to the HIV-1 Tat protein (Tombelli et al., 2005), hepatitis C virus (Seram et al., 
2007), herpes virus (Garai-lbabe et al., 2011), and plant virus (Gergely et al., 2010). For instance, 
aptamer-based piezoelectric QCM biosensor is investigated for detection of the protein trans-
activator of transcription (Tat) of HIV-1. In this work, a RNA aptamer as bio-recognition 
element for the HIV-1 Tat protein was immobilized on the gold electrode of the crystal, binding 
with streptavidin previously attached on the electrode surface (Minunni et al., 2004). The 
interaction with aptamer after addition of the Tat protein is monitored by the changes of the 
oscillation frequency of the crystal. To compare with immunosensors, this aptamer-based 
biosensor demonstrates excellent sensitivity, selectivity and reproducibility (Minunni et al., 
2004).   
2.4.4 Surface Plasmon Resonance (SPR) Biosensor 
The application of surface plasmon resonance (SPR) has been used almost three decades since 
1982 (Jiri et al., 1999), and SPR sensing has received continuous attention from the scientific 
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community since the first application. SPR-based optical biosensors are now being used 
extensively to define the kinetics of a wide variety of macromolecular interactions and high- and 
low-affinity small molecule interactions (Priyabrata, 2005). SPR-based biosensors significantly 
affect both basic and applied research.   
2.4.4.1 Principle of Surface Plasmon Resonance (SPR) 
Surface plasmons are actually a phenomenon of surface electromagnetic waves that occurs on 
interface of a metal and the external medium. The wave is very sensitive to any change of the 
interface, such as the adsorption of molecules to the metal surface.  
The surface plasmon resonance is from the stimulation of surface plasmon by light. To generate 
resonance by stimulating the surface plasmons, an electron or light beam is required (Priyabrata, 
2005). Generally, the p-polarized light is used because it can be passed through a layer of glass 
to increase the wave number and obtain the resonance at a given wavelength and angle. Silver 
and gold are the metals typically used for surface plasmons.  
Specifically, SPR is capable of detecting changes in refractive index (RI) occurring near the 
surface of a metal (within ~200 nm) (Sigal et al., 1997). Refractive index refers to the speed with 
which light passes through a material compared to the speed with which it passes through air. Its 
most elementary occurrence is in Snell’s law of refraction (Figure 2.7),  
                      sin θ1 RI1 = sin θ2 RI2                  (1) 
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 where θ1 and θ2 are the angles of incidence of a ray crossing the interface between two media 
with refractive indices RI1 and RI2. For example, light travels more slowly through glass than it 
does through air, therefore glass has a higher refractive index than air (RIglass = 1.5-1.6, RIair = 1) 
(Foster, 1997). A simple SPR instrument set-up generally consists of a light source, a glass prism 
with a high refractive index RI, a thin metal film placed in contact with the bottom of the prism 
and a optical detector (Figure 2.8 a). The molecular layer of interest can be coated onto the thin 
metal film may be coated with a molecular layer of interest on the side opposite the prism.  
 
Figure 2. 7 Refraction of light at the interface between two media. 
Surface plasmon waves (SPWs) can be generated at the interface between the conductive metal 
film and the insulating molecular layer by striking the metal sensor with a particular type of light 
(Caruso et al., 1998; Homola et al., 1999).  At the same time that SPWs are generated, light is 
also reflected off of the metal surface.  Past a specific incident angle (Figure 2.8), and only in the 
presence of the highly refractive glass prism, all the energy from the incident light wave will be 
transferred to the reflected light wave (total internal reflection) (Fishbane et al., 1993).  However, 
at  a very specific angle past the point of total internal reflection (the SPR angle), a majority of 
the incident light energy that would have typically been transferred to the reflected light wave 
will instead interact with the generated SPWs, resulting in a phenomenon called resonance 
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(Levesque et al., 1997; Stenberg et al., 1991).  At resonance, a minimum in reflected light 
intensity will be observed, and the SPR angle can thus be determined by measuring the intensity 
of the reflected light (via optical detector), and plotting it as a function of incidence angle (see 




Figure 2. 8 The configuration for measuring surface plasmon resonance: (a) Schematic diagram 
of SPR.When the incident light was used to the prism of SPR sensor, an angle of θ1 was formed 
which can be observed by the optical detector. Then, the targets were applied to the gold surface 
of the sensor chip and they specifically bound to the probes or aptamers in this research which 
resulted in the change of thickness of the gold surface. When the light source was used at that 
time, a different SPR angle θ2 was formed. The difference between both angles is highly related 
with the properties of the targets.   (b) Target binding. After targets were applied to the gold 
surface, they bound to the ligands on the surface with high or low affinity. The binding with low 
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affinity or nonspecific binding were washed away through using buffer solution, only leaving the 
binding with higher affinity.  
 
 
Figure 2. 9 Schematic diagram of SPR chip. Before and after the targets were used to the flow 
cell, the light formed different refractive angles due to the change of thickness of the gold 
surface. 
2.4.4.2 Kinetic Analysis of Surface Plasmon Resonance 
Surface plasmon resonance is a charge-density oscillation that may exist at the interface of two 
media with dielectric constants of opposite signs, for instance, a metal and a dielectric (Homola 
et al., 1999). The charge density wave is associated with an electromagnetic wave, the field 
vectors which reach their maxima at the interface and decay evanescently into both media 
(Homola et al., 1999). A SPW is a transverse-magnetic (TM) wave (magnetic vector is 
perpendicular to the direction of propagation of the SPW and parallel to the plane of interface) 
and is an electromagnetic wave which propagates along the boundary between a dielectric and a 
metal (Homola et al., 1999; Homola, 2003). A SPW is characterized by the propagation constant 




 where k is the free space wave number, εm is the dielectric constant of the metal, RI is the 
refractive index of the dielectric (Homola et al., 1999). At optical wavelengths, this condition is 
fulfilled by several metals of which gold and silver are the most commonly used (Ordal et al., 
1983).  
Due to the face that the vast majority of the field of a SPW is concentrated in the dielectric, the 
propagation constant of the SPW is extremely sensitive to changes in the refractive index of the 
dielectric (Homola, 2003). This property of SPW is the underlying physical principle of affinity 
SPR biosensors - biomolecular recognition elements on the surface of metal recognize and 
capture analyte present in a liquid sample producing a local increase in the refractive index at the 
metal surface. The refractive index increases give rise to an increase in the propagation constant 
of SPW propagating along the metal surface which can be accurately measured by optical means 
(Homola, 2003).   
2.4.4.3 Application of Surface Plasmon Resonance  
The SPR technique was used in the development and characterization of ultra-thin films (Yuan et 
al., 2007). Over the last decade, the SPR biosensor technique has received great research interest. 
SPR biosensors have become an established method for measuring molecular interactions. The 




The optical system, the sensor system and the detection system together build the whole SPR 
sensor system. The optical system includes the light source and the optical path used to produce 
the incident light fit for the performance requirements. The sensor system is applied in the 
transformation of sensitive information to the change of refractive index. Lastly, the detection 
system measures the intensity of the reflected light, and the position of the resonance adsorption 
peak is recorded for the further analysis (Yuan et al., 2007). Therefore, SPR biosensor 
experiments include the immobilization of one reactant on the metal surface and detection of its 
interaction with a second component in terms of the refractive index change near the sensor 
surface (Rebecca et al., 2000). The SPR biosensors can monitor the interactions between ligands 
and targets in real-time without labeling requirements. Subsequently, they can be used to detect 
the binding reactions of any biological system from proteins, oligonucleotides, oligosaccharides, 
and lipids to small molecules, phage, viral particles and cells (Rebecca et al., 2000). 
The SPR phenomenon has been known for a long time. However, the application of SPR-based 
biosensors is relatively new. Currently, SPR biosensor technology has obtained rapid 
development and improvement since the first use of SPR for biosensing purposes, being an 
effective alternative for analyzing biological interactions. There are a large number of papers 
reported the application of SPR biosensors, such as protein immobilization (Park et al., 2011; 
Oliveira et al., 2011), antibody selection and detection (Razavi et al., 2011; Nosach et al., 2009), 
bacteria immobilization (Arya et al., 2011), papillomavirus genotype (Wang et al., 2010), 
diagnosis of hepatitis B virus and dengue virus (Zheng et al., 2010; Kumbhat et al., 2010). A few 
studies on influenza virus detection using SPR biosensors have been reported, like avian 
influenza DNA hybrization (Kim et al., 2010), adamantane binding sites in the influenza A M2 
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ion channel (Rosenberg and Casarotto, 2010), and influenza virus hemagglutinin monitoring 

























Highly pathogenic avian influenza virus H5N1 has been a great threat for the poultry industry as 
well as for humans, causing high morbidity and mortality rate. In addition to containment 
procedures, sensitive detection assays for early diagnosis are important to reduce the chances of 
spread and lower the risk of development into an epidemic. However, current detection methods 
are either time-consuming, or expensive, or require complex techniques. A rapid and specific 
detection method of avian influenza virus H5N1 is needed and will become increasingly 
important and urgent in the face of concerns over the outbreaks of highly pathogenic avian 
influenza virus H5N1 and the cases of human infection. Here we developed a new technique to 
specifically detect the AI H5N1 in which an aptamer-based SPR biosensor was used as a 
transducer and the aptamer used was sequenced in our lab and specifically against AI H5N1.  
The specific objectives of this project were as follows: 
1. To optimize the parameters:  
In order to get the best data using minimum amount of material, incubation time and 
concentrations of streptavidin and aptamers were optimized.  
After SPR device was pretreated and set up, an aliquot of 250 μl of 0.025 mg/ml streptavidin was 
applied into the SPR flow cell and incubated for 25 min. After streptavidin immobilization, 1 ml 
of 10 mM PBS was applied to wash away the excess streptavidin and then the test was paused. 
The response data was collected through the software of Spreeta 5. Then, another new test for 
concentration optimization of streptavidin was started. In this research, the concentration of 
streptavidin used was 0.35, 0.20, 0.15, 0.10, 0.05, and 0.025 mg/ml, respectively. All procedures 
 46 
are the same in the concentration optimization except the concentration of streptavidin. Similarly, 
the concentration of aptamer was also optimized.  
After SPR pretreatments and set up were performed, streptavidin as a constant was injected into 
the SPR flow cell to incubate for 10 min. After streptavidin immobilization, PBS was applied to 
wash away the excess streptavidin and then the test was paused. The response data were 
collected. Then, another new test for time optimization of streptavidin was started. In this 
research, the streptavidin incubation time periods tested involved in 10 min, 15 min, 20 min, 25 
min, and 30 min, respectively. All procedures are the same in the time optimization except the 
streptavidin incubation time. Similarly, the incubation time of aptamer was also optimized.  
2. To determine the specificity and sensitivity of the SPR biosensor:  
In this research, both the targets against avian influenza H5N1 and not-targets were detected 
using SPR biosensor to obtain the response values. Through the comparison of the response 
values between targets and not-targets, the specificity of the aptamer could be determined.  
During this study, the aptamer-based SPR biosensor for detection of the avian influenza virus 
H5N1 was performed as well as Dot-blot for virus detection. Comparable study showed that the 
developed SPR biosensor was comparable to Dot-blot and had better sensitivity than Dot-blot.  

















4.1 Materials  
4.1.1 AI Virus 
Killed AIV H5N1 was provided by USDA-APHIS National Veterinary Services Laboratories 
(NVSL) in Ames, Iowa. The virus was inactivated by the USDA lab using β-propiolactone. The 
H5N1 virus used in the tests was isolated from chickens in Scotland in 1959. The stock 
concentration of the virus was 107 EID50/ml or the equivalent 128 HA titer. All dilutions were 
done using PBS (pH7.4).   
Killed non-target avian influenza viruses were obtained from Animal Diagnostic Laboratory 
(ADL) at Pennsylvaina State University, University Park, PA for use in specificity tests. 
Subtypes were picked for overlapping antigenic properties with AIV H5N1. Avian influenza 
virus subtypes H1N1, H2N2, H5N2, H7N2 and H9N2 were used. 
4.1.2 Aptamers 
The biotin-aptamers developed by Li et al. (2010) are specific against H5N1. They were 
synthesized by Integrated DNA Technologies (IDT), Coralville IA. Aptamers were dissolved to 
an appropriate dilution for use in the tests. In our study, we selected DNA aptamers rather than 
RNA aptamers due to several reasons. First, DNA aptamers are more stable in harsh conditions 
and can be used easily in the field. Second, they could function better without further 
modifications in detection and diagnostic assays where aptamers may have a contact with 
different biological samples for a short period of time. 
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4.1.3 Biological and Chemical Reagents 
Streptavidin was bought from Rockland, Gilbertsville, PA. Biotin-aptamers were specific 
against H5N1 and synthesized by Integrated DNA Technologies (IDT), Coralville IA. 
Streptavidin-AP was supplied by Sigma-Aldrich (St. Louis, MI). It also needed to be diluted with 
10 mM PBS to 1: 500. Bovine serum albumin was purchased from Sigma-Aldrich (St. Louis, 
MI), and it was dissolved in 10 mM PBS to a concentration of 0.5% and stored at 4 ℃ for use in 
the experiments. Tween20 was from Mallinckrodt (Hazelwood, MO) and was diluted with 10mM 
PBS to form a solution called PBST as washing solution, remaining a concentration of 0.25% 
and stored at 4 ℃ for use in the tests. BCIP/NBT was supplied by Kirkegaard and Perry 
Laboratories, Inc. (KPL, Gaithersburg, MD). as a substrate in Dot-ELISA tests and stored in a 
brown bottle. Phosphate buffered saline (PBS, 10X) was obtained from Sigma-Aldrich (St. Louis, 
MI) and diluted with Milli-Q (Milli-Q, Bedford, Massachusetts) pure water to 10 mM (pH 7.4) 
for the usage in the whole research. Sodium hydroxide (NaOH, solid) and hydrochloric acid 
(HCl, 36-38%) were all purchased from Sigma-Aldrich (St. Louis, MI) and then diluted with 
Milli-Q (Milli-Q, Bedford, Massachusetts) pure water to 1 M for the pretreatment of SPR 
electrode. Ethanol was supplied by Sigma-Aldrich (St. Louis, MI) for the pretreatment of SPR 
electrode. All the water used in the research was obtained from the Millipore water purification 
system (resistivity 18.2 MΩ cm; Milli-Q, Bedford, MA). 
4.1.4 Poultry Swab Samples 
Poultry swab samples were obtained from Poultry Health Lab, University of Arkansas, 
Fayetteville, AR. The swabs were obtained from the saliva in the chicken throat. Twelve tubes 
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with swabs were prepared in each of which two birds were used as well as 1 ml of PBS. First, 
each tube with swabs was mixed sufficiently using a votex mixer. After mixing, each swab was 
pressed against the tube wall several times and then discarded. All tubes of the solution, then, 
were combined into one tube. Finally, the solution was filtered using syringe filter (0.45 μm) and 
was spiked with avian influenza A virus H5N1 for further use. The original avian influenza 
H5N1 virus titers were diluted to different concentrations in the poultry swab solution. Pure 
swab solution without spiking with avian influenza A H5N1 virus was used as a control. 
4.2 Apparatus 
Nitrocellulose membrane was purchased from Schleicher & Schuell BioScience Inc. (Keene, NH) 
and then cut by clean scissors to prepare 60 mm X 12 mm test strips for five specimens. 1 ml-
syringeS were purchased from Sigma-Aldrich (St. Louis, MI). Spreeta SPR detector was 
purchased from Texas Instruments, Dallas, TX, and the system includes SPR sensor, 
integrated multichannel flow cell, and 12-bit interface box; DELL laptop, Latitude D610 or 
630. Several petri dishes were needed in the Dot block tests. The Vasi-Mix was used for laying 
the petri dishes and allowed nitrocellulose membrane strips to react sufficiently. 
4.3 Experimental Methods 
4.3.1 Surface Plasmon Resonance (SPR) Tests 
4.3.1.1 Pretreatments and Set Up 
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The Au surface of SPR biosensor was pretreated with 300 μl of 1 M NaOH for 20 min and 300 
μl of 1 M HCl for 5 min in order to get rid of any irregularities and obtain a clean Au surface (Su 
and Li, 2004; Autolab SPR). After pretreatment, the crystals were rinsed by spraying ethanol and 
water successively, and dried in a stream of nitrogen. The SPR sensor was then installed in the 
flow cell, initialized in the air and calibrated in deionized water. 1 ml of 10 mM Phosphate 
buffered saline (PBS, pH 7.4) was injected into the flow cell. After PBS injection, the change of 
refraction index can start to be monitored, and the first baseline in PBS can be obtained within 3 
to 5 min.  
4.3.1.2 Aptamer Immobilization  
The streptavidin was used to immobilize biotin-aptamer onto the cleaned Au surface due to 
strong affinity of streptavidin to the cleaned Au surface through physical adsorption.  An aliquot 
of 250 μl of 0.2 mg/ml streptavidin was applied to the flow cell and incubated for 25 min. 
After streptavidin immobilization, 1 ml of PBS was used to wash the excess streptavidin to 
get the second PBS baseline within 3 to 5 min. An aliquot of 300 μl of 2.04 μg/ml biotin-
aptamer was injected into the flow cell to bind to the binding sites on the streptavidin and 
incubated for 25 min. The excess aptamers were rinsed off using PBS, resulting in the third 
PBS baseline within 3 to 5 min.  
4.3.1.3 Virus Detection  
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After rinsing with PBS to remove the excess aptamers, an aliquot of 300 μ l of avian 
influenza A virus H5N1 diluted with PBS was then spread over the channel of Au surface 
and incubated for 25 min.  Every time the materials were immobilized, the excess was 
removed by rinsing with PBS, and so does the virus. Therefore, the forth PBS baseline can 
be received within 3 to 5 min.  
 
Figure 4. 1 Principle of SPR biosensor for detection of AIV H5N1. 
4.3.2 Dot-blot Test  
First of all, the nitrocellulose membrane was cut by clean scissors into 60 mm X 12 mm test 
strips for use in the tests. Vinyl gloves must be worn at all times when handling the nitrocellulose 
(NC) membrane. An aliquot of 5 μl of test viruses (H5N1, H9N2, H5N2, H2N2, H5N3, H5N9, 
H7N2, and H1N1) was added on the NC strips and allowed to air dry, using pencil to mark the 
upper side of the membrane. The strips were then transferred to a clean Petri dish and layed out 
one by one. Strips with different test specimens can be put together in the Petri dish but should 
not overlap. An aliquot of 0.5% BSA as a blocking solution was poured into the petri dish and 
cover every strips. The strips were allowed to react for 15 – 30 min on the shaker. After the 
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reaction, the strips were removed and lay out on chromatography paper to air dry, and then 
transferred into a new petri dish. An aliquot of 1: 1000 aptamers were applied to the strips and 
cover the entire strips surface (do not need to pour, only add 150 μl on every strip) and incubated 
for 45 min. The strips were then washed with a PBST solution three times and each wash 
requires a 5 min soak period on the shaker. After wash, strips were taken out from the dish and 
allowed to air dry.  
The dried strips were consequently transferred into another new Petri dish. An aliquot of 200 μl 
of 1: 500 streptavidin-AP was applied to conjugate aptamers, allowing the reaction to go for 25 
min. The strips were then washed with a PBST solution three times and each wash requires a 5 
min soak period on the shaker. After wash, strips were taken out from the dish and allowed to air 
dry. 
Finally, the strips were transferred into another new Petri dish. The BCIP/NBT substrate was 
added to the strips, remaining the substrate and the strips in the dark to allow for color 
development. A purple color was evident within 5 min. In order to avoid the strong background, 
the color developing time shouldn’t last too long. The color development can be stopped by 
immersing the strips in water for 10 – 20 s. The strips were kept in the dark to air dry, and then 
stored in sealed plastic and kept in the dark to prevent the color from fading.  
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Figure 4. 2 Principle of Dot-blot analysis for detection of AI virus. 
4.4 Data Collection and Statistical Analysis 
All the SPR data were recorded using the software of Spreeta 5. Microsoft Excel was used for 
statistical analysis of all data, including determination of means and standard deviation. The data 
were used to plot in a figure with figure title, x and y axis titles and units. Arrows and words 
were used to indicate where the streptavidin, aptamers and H5N1 as well as washing were started. 
The response values caused by immobilized streptavidin, aptamers and captured H5N1 were 
calculated and listed with a table title.  The factors that can affect the performance of the SPR 
immunosensor in virus detection were discussed based on the data collected. Some measures to 


















5.1 Optimization of Parameters 
5.1.1 Streptavidin Optimization  
5.1.1.1 Streptavidin Concentration 
An aliquot of 5 mg of streptavidin powder was dissolved with 1ml of 10 mM PBS. Then the 5 
mg/ml of streptavidin solution was packed into 1.5-ml tube with 200 μl /tube and stored in the -
20℃ for the future tests. As discribed in 4.3.1, after SPR device was pretreated and set up, an 
aliquot of 250 μl of 0.025 mg/ml streptavidin was applied into the SPR flow cell and incubated 
for 25 min. After streptavidin immobilization, 1 ml of 10 mM PBS was applied to wash away the 
excess streptavidin and then the test was paused. The response data was collected through the 
software of Spreeta 5. Then, another new test for concentration optimization of streptavidin was 
started. In this research, the concentration of streptavidin used was 0.35, 0.20, 0.15, 0.10, 0.05, 
and 0.025 mg/ml, respectively. All procedures are the same in the concentration optimization 
except the concentration of streptavidin. The sorted data was listed in the table below. The 
histogram for concentration optimization of streptavidin was also shown. Based on data shown in 
that table and the histogram, the response values from 0.025 to 0.2 mg/ml were increased 
gradually, but after 0.2 mg/ml, the values tend to become more stable. Therefore, a conclusion 




Table 5. 1 Optimization of streptavidin concentration. 
 
Con. of Streptavidin (mg/ml)        Refractive Index (RI) * 106            Mean ± Std (RI*106) 
                   0.25                                   414          529        582                              508 ± 86 
                   0.05                                   743          969        693                             802 ± 147 
                    0.1                                    978          879       1174                           1010 ± 150 
                   0.15                                  1319        1428      1291                            1346 ± 72 
                   0.20                                  2047        2022      1911                            1993 ± 72 
                   0.35                                  1924        2212      1907                           2014 ± 171 
 
 
Figure 5. 1 Optimization of streptavidin concentration in SPR biosensor. Six different 
concentrations of streptavidin (0.025, 0.05, 0.1, 0.15, 0.2, and 0.35 mg/ml) was used to the SPR 
biosensor. The streptavidin was incubated for 25 min. Three repeated tests were performed. 
Means and standard deviations were calculated.  
 
5.1.1.2 Streptavidin Incubation Time 
As described in 4.3.1, after SPR pretreatments and set up were performed, an aliquot of 250 μl of 
0.2 mg/ml streptavidin as a constant was injected into the SPR flow cell to incubate for 10 min. 
After streptavidin immobilization, 1 ml of 10 mM PBS was applied to wash away the excess 




Spreeta 5. Then, another new test for time optimization of streptavidin was started. In this 
research, the streptavidin incubation time periods tested involved in 10 min, 15 min, 20 min, 25 
min, and 30 min, respectively. All procedures are the same in the time optimization except the 
streptavidin incubation time. The sorted data were listed in the table below. The histogram for 
time optimization of streptavidin was also shown.  Based on that table and the histogram, the 
response values from 10-min to 25-min periods were increased gradually, but after 25-min 
period, the values tend to become more stable. Therefore, a conclusion can be made that the 
optimal incubation time for streptavidin is 25 min in SPR tests.   
Table 5. 2 Optimization of streptavidin incubation time. 
 
               Time (min)       Refractive Index (RI) * 106         Mean ± Std (RI*106) 
                    10                       546       746        853                         715 ± 156 
                    15                      1142      989       1072                        1068 ± 77 
                    20                      1700      1273     1326                       1433 ± 233 
                    25                      2126      1956     2267                       2128 ± 158 
                    30                      1552      2526     2219                       2099 ± 498 
 
 
Figure 5. 2 Optimization for streptavidin incubation time in SPR biosensor. Five different time 
periods (10, 15, 20, 25, and 30 min) were used for streptavidin incubation. The concentration of 





5.1.2 Aptamer Optimization  
5.1.2.1 Aptamer Thermal Treatments 
As mentioned in 4.3.1.2, biotinylated aptamer immobilization is followed just after streptavidin 
immobilization. Before aptamers were injected into the flow cell, they were thermally treated in 
order to unfold the aptamer DNA strand making the biotin label at the 5’ end available for the 
interaction with streptavidin on the electrode surface (Tombelli et al., 2005). In this research, the 
biotinylated aptamers were thermally treated by three methods: a. the original aptamer solution 
without any thermal treatments, b. the aptamers were boiled for 5 min, and then cooled down for 
30 min in room temperature, c. the aptamers were boiled for 5 min, and then cooled down in ice 
for 1 min in order to stabilize the DNA in its unfolded structure. Aptamer a were injected into 
the SPR flow cell after streptavidin immobilization. Then aptamer b and c were also applied in 
another two new tests. Based on the data collected, aptamer a and b didn’t show any readable 
signal, but aptamer c gave identifiable signal change. Thus, method c was used for aptamer 
thermal treatment in the whole research. 
5.1.2.2 Aptamer Concentration  
As shown in 4.3.1.2, aptamer was injected following streptavidin immobilization. After that, 1 
ml of 10mM PBS was applied to wash away the excess aptamer and then the test was paused. 
Then, another new test for concentration optimization of aptamer was started. In this research, 
the concentration of aptamer used was 1.2, 1.6, 1.8, 2.0, and 2.5 µg/ml, respectively. All 
procedures are the same in the concentration optimzation except the concentration of aptamers. 
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The sorted data was listed in the table below. The histogram for optimization of aptamer 
concentration was also shown. Based on the data shown in the table and the histogram, the 
response values from 1.2 to 2.0 µg/ml were increased gradually, but after 2.0 µg/ml, the values 
tend to become more stable. Therefore, a conclusion can be made that the optimal concentration 
for aptamers is 2.0 µg/ml SPR tests.   
Table 5. 3 Optimization of aptamer concentration. 
 
     Con. of aptamer (µg/ml)          Refractive Index (RI) * 106          Mean ± Std (RI*106) 
                         1.2                                   62          75        96                            78 ± 17 
                         1.6                                  158        149      241                          183 ± 51 
                         1.8                                  294        247      352                          298 ± 53 
                         2.0                                  444        569      481                          498 ± 64 




Figure 5. 3 Optimization of aptamer concentration in SPR biosensor. Five different 
concentrations of aptamers (1.2, 1.6, 1.8, 2.0, and 2.5 µg/ml) was used to the SPR sensor. The 
aptamers were incubated for 25 min. Three repeated tests were performed. Means and standard 
deviations were calculated. 
5.1.2.3 Aptamer Incubation Time 
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Based on the optimization of streptavidin, 0.2 mg/ml of streptavidin to be incubated for 25 min 
was used for streptavidn immobilization in the future tests. For the concentration of biotinylated 
aptamer, 2.0 μg/ml of it was applied in the future tests as mentioned above. As described in 
4.3.1.2, after streptavidin was immobilized and biotinylated aptamers were thermally treated, an 
aliquot of 300 μl of 2.0 μg/ml of aptamer thermally treated as a constant was injected into the 
SPR flow cell to incubate for 10 min. After aptamer incubation, 1 ml of 10 mM PBS was applied 
to wash away the excess streptavidin and then the test was paused. The response data were 
collected by the software of Spreeta 5. Then, another new test for time optimization of aptamer 
was started. In this research, the aptamer incubation time periods tested included 10 min, 15 min, 
20 min, 25 min, and 30 min, respectively. All procedures are the same in the time optimzation 
except the aptamer incubation time. The sorted data was listed in the table below. The histogram 
for time optimization of aptamer was also shown. Based on the data in that table and the 
histogram, the response values from 10-min to 25-min periods were increased gradually, but 
after 25-min period, the values tend to become more stable. Therefore, a conclusion can be made 
that the optimal incubation time for aptamer is 25 min in SPR tests.   
Table 5. 4 Optimization of aptamer incubation time. 
               Time (min)      Refractive Index (RI) * 106          Mean ± Std (RI*106) 
                    10                       263       207        217                          229 ± 30 
                    15                       207       412        367                         329 ± 108 
                    20                       405       231        295                          310 ± 88 
                    25                       481       509        541                          510 ± 30 
                    30                       503       439        587                          510 ± 74 
 








Figure 5. 4 Optimization of aptamer incubation time in SPR biosensor. Five different time 
periods (10, 15, 20, 25, and 30 min) were used for aptamer incubation. The concentration of 
aptamer was 2.0μg/ml. Three repeated tests were performed. Means and standard deviations 
were calculated. 
 
5.2 Detection of Avian Influenza Virus 
5.2.1 AI Virus in Pure Culture 
After parameters optimizations, avian influenza virus H5N1 was detected as described in 4.3.1. 
A typical curve of AIV H5N1 detection using SPR biosensor is shown in Figure 5.6. The first 
blue line is PBS baseline. Then, streptavidin was immobilized on the gold surface of SPR chip, 
causing the refractive index changes and forming the second blue line. In order to wash away the 
excess streptavidin, PBS was applied to the chip surface, resulting in the second PBS baseline. 
The difference between the first PBS baseline and the second PBS baseline was the signal 
change of the streptavidin in terms of refractive index (0.001816585 RI shown in Figure 5.6. 
Similarly, the signal change of aptamers can be obtained by subtracting the value of the second 
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PBS baseline from the value of the third PBS baseline. The refractive index change of AIV 
H5N1 is equal to the difference between the values of the fourth and the third PBS baseline. 
Based on the collected data (the data weren’t shown on this paper), the developed SPR biosensor 
cannot read the refractive index of AIV H5N1 with the titer of 0.0128 HAU. From 0.128 HAU to 
1.28 HAU, the refractive index showed a great linear correlation with the R2 of 0.99 (Figure 5.5). 
After 1.28 HAU, the signal tended to become stable (Figure 5.5). Therefore, the detection limit 
was 0.128 HAU (minimum) and 1.28 HAU (maximum). The calibration curve and regressive 
curve of H5N1 detection was shown in Figure 5.5.  
Table 5. 5 Result of the tests for detection of AIV H5N1 in pure culture. 
 
     Con. of H5N1 (HAU)     Refractive Index (RI) * 106          Mean ± Std (RI*106) 
                  0.128                        91              28            147                           89 ± 60 
                   0.32                        276            315           196                          262 ± 61 
                   0.64                        823            518           577                         639 ± 161 
                   1.28                       1156          1090         1165                        1137 ± 41  








Figure 5. 6 A typical response curve of aptamer-based SPR biosensor to the surface 
modification and AIV H5N1 detection. 
5.2.2 AI Virus in Poultry Swab Samples 
The procedure for detection of poultry swab sample was the same as that for detection of AIV 
H5N1 except virus dilution. The AIV H5N1 was dissolved with poultry swab sample instead of 
PBS which was used in the previous detection of pure virus. With the increase of the virus titer, 
the value of refractive index gradually ascended. Due to the impurities and/or other materials like 
other proteins in the swab sample which might have a negative impact on the binding of virus to 
the aptamer, the number of virus particle that were responsible for the detection signal may be 
less than that of virus diluted with PBS. Therefore, no platform of signal can be found in the 






Table 5. 6 Result of the tests for detection of AIV H5N1 in poultry swab samples. 
 
     Con. of H5N1 (HAU)       Refractive Index (RI) * 106           Mean ± Std (RI*106) 
                Control                        8               -7             1                                1 ± 8 
                 0.0128                      145            96            109                          117 ± 25 
                   0.32                        257           198           175                          210 ± 42 
                   0.64                        511           259           535                         435 ± 153 
                   0.96                        710           514           599                          608 ± 98 
                   1.28                        875           707          1028                        870 ± 161  
                   12.8                        812          1067          899                         926 ± 130 
 
 
Figure 5. 7 Aptamer-based SPR biosensor for detection of AIV H5N1 in poultry swab samples. 
Six different concentrations of avian influenza virus H5N1in poultry swab samples (0.128, 0.32, 
0.64, 0.96, 1.28 and 12.8 HAU) were applied to the flow cell of SPR biosensor. PBS was used 
for the control instead of H5N1. Three repeated tests were performed. Means and standard 






Figure 5. 8 A typical response curve of aptamer-based SPR biosensor to the surface 
modification and detection of AIV in poultry swab samples. 
 
 
5.2.3 Comparison between Biosensor and Dot-blot Tests 
As described in 4.3.2, Dot-blot experiments were performed. The experimental data are shown in 
Figure 5.9. Based on the data in Figure 5.9 a which was Dot-blot for detection of AIV H5N1 
with different dilutions, the minimum detection limit that was able to read in Dot-blot 
experiments was 12.8 HAU of AIV H5N1 while the detection limit tested using developed SPR 
biosensor was 0.128 HAU (Shown in Figure 5.5). Therefore, the developed SPR biosensor has 
better sensitivity than Dot-blot. 
As shown in Figure 5.9 c that was the comparison experiment between H5N1 and not-targets, 
only AIV H5N1 were responsible for the purple dots on the stripes, while non-target subtypes 
didn’t show any symbol. Consequently, the comparison study between AIV H5N1 and non-
targets using Dot-blot illustrated that the biotinylated aptamer had higher specificity for H5N1 






                                                                   (c) 
 
Figure 5. 9 Results of Dot-blot tests: (a) Detection of pure AIV H5N1; (b) Detection of AI 
H5N1 in Poultry swab samples; (c) comparison between AIV H5N1 and non-targets of other 
AIV subtypes. 
 
Based on the Figure 5.9 b, Dot-blot was also able to detect the poultry swab samples, and the 
minimum detection limit was 1.28 HAU, while the detection limit of SPR biosensor was 0.128 
(a) (b) 
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HAU (Shown in Figure 5.7). The comparison study also showed that the developed SPR 




























An aptamer-based SPR biosensor was designed, fabricated, and tested for the detection of AIV 
H5N1 in poultry swab samples. The optimum parameters were obtained for the concentration 
and incubation time of streptavidin (0.2 mg/ml, 25 min) and aptamers (2.0 µg/ml, 25 min). A 
good correlation (R2=0.99) was found between AIV concentration in the range of 0.128 to 1.28 
HAU and the refractive index. The specificity of aptamer-based SPR biosensor was confirmed 
by comparison of AIV H5N1 with other non-target AIV subtypes such as AIV H1N1, H2N2, 
H5N2, H7N2, and H9N2, which showed that no interference was observed from these non-target 
subtypes. The developed SPR biosensor was able to detect AIV H5N1 in the poultry swab 
samples with a lower detection limit of 0.128 HAU in 1.5 h. The aptamer-based SPR biosensor 
has potential to provide the poultry industry a new method for in-field detection of avian 





















For future improvement of this SPR biosensor, several issues can be addressed:  
1) In this research , the streptavidin was immobilized through physical adsorption which is 
relatively weak. In order to firmly immobilize the material on the sensor surface, self-
assembled monolayer is suggested to replace the physical adsorption.  A self assembled 
monolayer (SAM) is an organized layer of amphiphilic molecules in which one end of the 
molecule, the “head group” shows a specific, reversible affinity for a substrate. SAMs 
also consist of a tail with a functional group at the terminal end. Adsorbate molecules 
adsorb readily because they lower the surface free-energy of the substrate (Love et al., 
2005) and are stable due to the strong chemisorption of the “head groups.” These bonds 
create monolayers that are more stable than the physisorbed bonds of Langmuir–Blodgett 
films (Madou and Marc, 2002; Kaifer and Angel, 2001).  
2) The poultry swab samples used in this study were pretreated using 0.45 μm syringe filter. 
There might still be some impurities or other proteins that may affect the detection of 
virus. To prepare better testing sample from the poultry swab samples, magnetic 
separation method may be considered for use in the future research.  Magnetic separation 
is a process in which magnetically susceptible material is extracted from a mixture using 
a magnetic force. Small super-magnetic particles or beads coated with ligands against 
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